Hsp70-peptide TKD/IL-2-activated autologous natural killer cells
Term · Oncology and biomedicine · MLC-T-ONC-014199
A preparation of autologous natural killer (NK) cells that are stimulated ex vivo by a 14-mer heat shock protein 70 (Hsp70) TKD peptide and interleukin-2 (IL-2), with potential tumor-selective cytolytic activity. Upon re-infusion into the patient, the treated NK cells recognize and bind to Hsp70-expressing tumor cells, which induces NK-mediated tumor cell lysis. Hsp70, a membrane-bound, stress-inducible protein, is overexpressed on almost all tumor cells; however, it is absent or minimally present on normal, healthy cells. TKD is the C-terminal substrate-binding domain of Hsp70 and is the structure recognized by the activated NK cells.
| Identifier | MLC-T-ONC-014199 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Hsp70-peptide TKD/IL-2-activated autologous NK cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014199",
"term": "Hsp70-peptide TKD/IL-2-activated autologous natural killer cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous natural killer (NK) cells that are stimulated ex vivo by a 14-mer heat shock protein 70 (Hsp70) TKD peptide and interleukin-2 (IL-2), with potential tumor-selective cytolytic activity. Upon re-infusion into the patient, the treated NK cells recognize and bind to Hsp70-expressing tumor cells, which induces NK-mediated tumor cell lysis. Hsp70, a membrane-bound, stress-inducible protein, is overexpressed on almost all tumor cells; however, it is absent or minimally present on normal, healthy cells. TKD is the C-terminal substrate-binding domain of Hsp70 and is the structure recognized by the activated NK cells.",
"synonyms": [
"Hsp70-peptide TKD/IL-2-activated autologous NK cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/hsp70-peptide-tkd-il-2-activated-autologous-natural-killer-cells/"
}
Record 8,680 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.